Form 4: Nutex Health COO Joshua DeTillio Reports Stock Transactions

Joshua DeTillio, Chief Operating Officer of Nutex Health, Inc., reports the vesting and subsequent sale of shares to cover tax obligations.

Summary

• On March 1, 2025, Joshua DeTillio, the Chief Operating Officer of Nutex Health, Inc., had restricted stock units (RSUs) convert into 2,125 shares of common stock.
• Also on March 1, 2025, DeTillio disposed of 2,125 shares at $0.
• On April 4, 2025, DeTillio disposed of 452 shares at a price of $72.0972 to cover tax withholding obligations.
• Following these transactions, DeTillio directly owns 6,481 shares of Nutex Health, Inc.
• On March 10, 2025, DeTillio was granted 5,950 RSUs, vesting in three equal installments on March 1, 2026, March 1, 2027, and March 1, 2028.
• Following these transactions, DeTillio directly owns 10,200 derivative securities.

Sentiment

Score: 5

Explanation: This is a neutral report of stock transactions. It doesn't inherently indicate positive or negative sentiment about the company's performance.

Future Outlook

The reporting person will receive shares of common stock as the restricted stock units vest over the next three years.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company executives.

Stakeholder Impact

• Shareholders are informed about the transactions of a key executive, providing transparency.

Key Dates

Keywords

Form 4, Nutex Health, Joshua DeTillio, Stock Transactions, Restricted Stock Units, RSUs, Common Stock, Insider Trading